Chemotherapy-induced hearing loss: the applications of bio-nanotechnologies and bile acid-based delivery matrices

Ther Deliv. 2021 Oct;12(10):723-737. doi: 10.4155/tde-2021-0050. Epub 2021 Oct 26.

Abstract

Advancement in the prevention of chemotherapy-induced hearing loss has proposed new nano-based delivery matrices that can target inner ear regions most damaged by chemotherapy. Chemotherapy agents (e.g., cisplatin) induce increased reactive oxygen species formation in the inner ear that damage sensory hair cells and result in irreversible hearing impairment. Exogenous antioxidants (e.g., Probucol and metformin) have been shown to block the formation of these reactive oxygen species. Delivery of these drugs in effective concentrations remains a challenge. Microencapsulation in combination with drug excipients provides one technique to effectively deliver these drugs. This paper investigates the use of probucol and metformin in combination with drug excipients for novel, inner ear, delivery.

Keywords: bile acid; cisplatin; metformin; micro-capsules; probucol.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents* / adverse effects
  • Bile Acids and Salts
  • Hearing Loss* / chemically induced
  • Humans
  • Nanotechnology

Substances

  • Antineoplastic Agents
  • Bile Acids and Salts